Vadim Bul

Vadim Bul practices at Sutter Roseville Endoscopy Center in Roseville, California.

Vadim Bul's NPI, 1629498274, was assigned on April 22, 2014. Vadim Bul graduated from Feinberg School of Medicine in 2014. Vadim Bul holds California license A169119.

Vadim Bul's primary practice is Sutter Roseville Endoscopy Center, at 4 Medical Plaza Drive, Suite 210, Roseville, CA 95661. The practice phone is (916) 773-8780.

Vadim Bul's primary practice is Sutter Roseville Endoscopy Center in Roseville, California. Vadim Bul is also affiliated with Sutter Roseville Medical Center. The medical group on file is SGMF Radiology. Dmand AI also links Vadim Bul to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Vadim Bul practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Vadim Bul's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Vadim Bul is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Vadim Bul's licenses on file in 2 states: California and Illinois.

Dmand AI lists acid reflux, atrial fibrillation and flutter, chronic anemia, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, fibromyalgia and chronic pain, gastroenteritis and gastrointestinal bleeding among the conditions Vadim Bul treats.

CMS data shows 654 Medicare services from Vadim Bul across 9 procedure codes in 2024, for 328 Medicare patients. Medicare paid $69,838 for them.

CMS counts 328 Medicare patients who saw Vadim Bul in 2024. The largest group is 65 to 74, with 174 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Vadim Bul's median patient age at 61, with 54% women.

In 2024, Vadim Bul wrote 1,076 Medicare Part D claims for 479 patients. 88% of them were for generic drugs. CMS names the drug for 942 of them, across 17 drugs with 11 or more claims each, at $90,492 in total drug cost. In 2023, CMS named 740 claims across 12 drugs.

Vadim Bul accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Vadim Bul as offering telehealth. CMS counts 88 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Vadim Bul, more than 74% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Vadim Bul, published from 2011 to 2017. 2016 was the busiest year, with 2. The most frequent topics are Emphysema and Multiple Organ Failure. Vadim Bul's most frequent co-authors are Cemal Yazici, MD, Brian Robert Boulay, MD and Barbara Hedwig Jung, MD.

CMS Open Payments shows 29 general payments to Vadim Bul from 14 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $170.

Vadim Bul graduated from Feinberg School of Medicine in 2014.

Vadim Bul is in network with 13 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.